CNN  — 

The Biden administration unveiled Tuesday the names of the first 10 drugs subject to price negotiations in Medicare.

They are: Eliquis, Jardiance, Xarelto, Januvia, Farxiga, Entresto, Enbrel, Imbruvica, Stelara, and Fiasp and certain other insulins made by Novo Nordisk, including NovoLog.

Once set, the negotiated prices take effect in 2026 – though the drug industry has filed multiple lawsuits seeking to derail the effort.

This story is breaking and will be updated.